HOUT-28. OFF-LABEL USE OF PD-1 BLOCKADE WITH OR WITHOUT BEVACIZUMAB CONFERS ONLY LIMITED CLINICAL BENEFIT IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA
| Image |  |
|---|---|
| Description | |
| Author/s |
author: Lakshmi Nayak Lais P Cabrera David A Reardon Mikael Rinne Eudocia Q Lee Patrick Y Wen |
| Publication date | November 6, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |